Annual Cash & Cash Equivalents
$188.23M$80.66M+74.98%
Summary
- Current Value
- As of today, AGL annual cash & cash equivalents is $188.23M, up +74.98% on
- Historical Performance
- AGL annual cash & cash equivalents is down -81.90% over the past 3 years, and up +52.25% over the past 5 years
- All-Time High Comparison
- AGL annual cash & cash equivalents is currently -81.90% below its historical high of $1.04B set on
- 3-Year Low Comparison
- AGL annual cash & cash equivalents is +74.98% above its 3-year low of $107.57M reached on
- Sector Comparison
- AGL annual cash & cash equivalents is higher than 77.61% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $188.23M | +75.0% | -81.9% | +52.3% | +52.3% | |
| Quarterly Cash & Cash Equivalents | $310.85M | -22.0% | -68.0% | – | – | |
| Price | $0.99 | -72.1% | -95.2% | – | – | |
| Annual Current Assets | $1.46B | -1.5% | +6.6% | +493.7% | +493.7% | |
| Annual Total Liabilities | $1.26B | +17.0% | +155.3% | +257.0% | +257.0% | |
| Annual Working Capital | $305.77M | -39.2% | -69.7% | +565.9% | +565.9% | |
| Annual Net Income | -$250.28M | -28.2% | +38.3% | -118.7% | -118.7% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $465.30M | N/A | -59.5% |
| 5Y | $1.04B | -81.9% | |
| All | $1.04B | -81.9% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $107.57M | +75.0% | |
| 5Y | $106.80M | N/A | +76.3% |
| All | $106.80M | +76.3% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $188.23M | +75.0% | |
| $107.57M | -76.9% | |
| $465.30M | -55.3% |
| Year | Value | Change |
|---|---|---|
| $1.04B | +873.9% | |
| $106.80M | -13.6% | |
| $123.63M | - |
FAQ
What is the current annual cash & cash equivalents of AGL?
As of today, AGL annual cash & cash equivalents is $188.23M
What is 1-year change in AGL annual cash & cash equivalents?
AGL annual cash & cash equivalents is up +74.98% year-over-year
What is 3-year change in AGL annual cash & cash equivalents?
AGL annual cash & cash equivalents is down -81.90% over the past 3 years
How far is AGL annual cash & cash equivalents from its all-time high?
AGL annual cash & cash equivalents is currently -81.90% below its historical high of $1.04B set on December 31, 2021
How does AGL annual cash & cash equivalents rank versus sector peers?
AGL annual cash & cash equivalents is higher than 77.61% of companies in Healthcare sector
When is AGL next annual earnings release?
The next annual earnings release for AGL is on
Quarterly Cash & Cash Equivalents
$310.85M$16.15M-4.94%
Summary
- Current Value
- As of today, AGL quarterly cash & cash equivalents is $310.85M, down -4.94% on
- Historical Performance
- AGL quarterly cash & cash equivalents is down -22.00% year-over-year, and down -68.03% over the past 3 years
- All-Time High Comparison
- AGL quarterly cash & cash equivalents is currently -72.39% below its historical high of $1.13B set on
- 3-Year Low Comparison
- AGL quarterly cash & cash equivalents is at its 3-year low
- Sector Comparison
- AGL quarterly cash & cash equivalents is higher than 78.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $310.85M | -4.9% | -22.0% | -68.0% | – | |
| Annual Cash & Cash Equivalents | $188.23M | – | +75.0% | -81.9% | +52.3% | |
| Price | $0.99 | +5.2% | -72.1% | -95.2% | – | |
| Quarterly Current Assets | $1.34B | -7.9% | -26.1% | -18.1% | – | |
| Quarterly Total Liabilities | $1.29B | -1.1% | -14.9% | +64.3% | – | |
| Quarterly Working Capital | $98.15M | -51.8% | -75.6% | -89.9% | – | |
| Quarterly Net Income | -$110.21M | -5.6% | +5.3% | -261.3% | -795.9% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $405.60M | N/A | -23.4% |
| 3Y | $887.81M | N/A | -65.0% |
| 5Y | $1.13B | -72.4% | |
| All | $1.13B | -72.4% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $310.85M | at low | |
| 3Y | $310.85M | at low | |
| 5Y | $119.49M | +160.2% | |
| All | $119.49M | +160.2% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of AGL?
As of today, AGL quarterly cash & cash equivalents is $310.85M
What is AGL quarterly cash & cash equivalents most recent change?
AGL quarterly cash & cash equivalents was down -4.94% on September 30, 2025
What is 1-year change in AGL quarterly cash & cash equivalents?
AGL quarterly cash & cash equivalents is down -22.00% year-over-year
How far is AGL quarterly cash & cash equivalents from its all-time high?
AGL quarterly cash & cash equivalents is currently -72.39% below its historical high of $1.13B set on June 30, 2021
How does AGL quarterly cash & cash equivalents rank versus sector peers?
AGL quarterly cash & cash equivalents is higher than 78.61% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- AGL Official Website www.agilonhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1831097/000162828025048839/0001628280-25-048839-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1831097/000162828025007721/0001628280-25-007721-index.htm
- AGL Profile on Yahoo Finance finance.yahoo.com/quote/AGL
- AGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agl